Weighted Average Number of Shares Outstanding, Basic of ImmunoGen, Inc. from 30 Sep 2010 to 30 Sep 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ImmunoGen, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2010 to 30 Sep 2023.
  • ImmunoGen, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2023 was 273,341,000, a 7.8% increase year-over-year.
  • ImmunoGen, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 253,631,000, a 23% increase from 2021.
  • ImmunoGen, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 206,147,000, a 17% increase from 2020.
  • ImmunoGen, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 176,153,000, a 19% increase from 2019.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ImmunoGen, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 273,341,000 +19,830,000 +7.8% 01 Jul 2023 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 263,446,000 +10,110,000 +4% 01 Apr 2023 30 Jun 2023 10-Q 31 Jul 2023 2023 Q2
Q1 2023 258,848,000 +5,585,000 +2.2% 01 Jan 2023 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 253,631,000 +47,484,000 +23% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
Q3 2022 253,511,000 +48,667,000 +24% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 253,336,000 +53,446,000 +27% 01 Apr 2022 30 Jun 2022 10-Q 31 Jul 2023 2023 Q2
Q1 2022 253,263,000 +54,428,000 +27% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q4 2021 206,147,000 01 Oct 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 204,844,000 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 199,890,000 01 Apr 2021 30 Jun 2021 10-Q 01 Aug 2022 2022 Q2
Q1 2021 198,835,000 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2016 87,035,000 +955,000 +1.1% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2016 2016 Q3
Q4 2015 86,970,000 +1,035,000 +1.2% 01 Oct 2015 31 Dec 2015 10-Q 04 Feb 2016 2016 Q2
Q1 2015 86,080,000 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q3
Q4 2014 85,935,000 +504,000 +0.59% 01 Oct 2014 31 Dec 2014 10-Q 04 Feb 2016 2016 Q2
Q4 2013 85,431,000 +1,284,000 +1.5% 01 Oct 2013 31 Dec 2013 10-Q 05 Feb 2015 2015 Q2
Q4 2012 84,147,000 +7,624,000 +10% 01 Oct 2012 31 Dec 2012 10-Q 05 Feb 2014 2014 Q2
Q1 2012 76,961,000 +8,894,000 +13% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2012 2012 Q3
Q4 2011 76,523,000 +8,558,000 +13% 01 Oct 2011 31 Dec 2011 10-Q 31 Jan 2012 2012 Q2
Q3 2011 76,364,000 +8,420,000 +12% 01 Jul 2011 30 Sep 2011 10-Q 31 Oct 2011 2012 Q1
Q1 2011 68,067,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q3
Q4 2010 67,965,000 01 Oct 2010 31 Dec 2010 10-Q 31 Jan 2012 2012 Q2
Q3 2010 67,944,000 01 Jul 2010 30 Sep 2010 10-Q 31 Oct 2011 2012 Q1

ImmunoGen, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 253,631,000 +47,484,000 +23% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023 2022 FY
2021 206,147,000 +29,994,000 +17% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
2020 176,153,000 +27,842,000 +19% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 148,311,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.